nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Epirubicin—urinary bladder cancer	0.191	0.26	CbGbCtD
Fluorescein—ABCC1—Etoposide—urinary bladder cancer	0.149	0.202	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—urinary bladder cancer	0.143	0.194	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—urinary bladder cancer	0.101	0.138	CbGbCtD
Fluorescein—ABCC1—Methotrexate—urinary bladder cancer	0.0982	0.134	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—urinary bladder cancer	0.0532	0.0724	CbGbCtD
Fluorescein—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—CYP4B1—urinary bladder cancer	0.00297	0.0596	CbGpPWpGaD
Fluorescein—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—PRSS3—urinary bladder cancer	0.00284	0.0571	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00269	0.054	CbGpPWpGaD
Fluorescein—CYP1A1—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00222	0.0446	CbGpPWpGaD
Fluorescein—CYP1A1—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00196	0.0395	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00159	0.032	CbGpPWpGaD
Fluorescein—ABCC1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00148	0.0298	CbGpPWpGaD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.00116	0.0232	CbGpPWpGaD
Fluorescein—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00111	0.0222	CbGpPWpGaD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000899	0.0181	CbGpPWpGaD
Fluorescein—CYP1A1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000884	0.0177	CbGpPWpGaD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000877	0.0176	CbGpPWpGaD
Fluorescein—CYP1A1—Estrogen metabolism—NQO1—urinary bladder cancer	0.000858	0.0172	CbGpPWpGaD
Fluorescein—ABCC1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000789	0.0158	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000764	0.0153	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000754	0.0151	CbGpPWpGaD
Fluorescein—CYP1A1—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.00067	0.0135	CbGpPWpGaD
Fluorescein—ABCC1—S1P1 pathway—RHOA—urinary bladder cancer	0.000658	0.0132	CbGpPWpGaD
Fluorescein—CYP1A1—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000658	0.0132	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000633	0.0127	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000619	0.0124	CbGpPWpGaD
Fluorescein—ABCC1—S1P1 pathway—PTGS2—urinary bladder cancer	0.000596	0.012	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidative Stress—NQO1—urinary bladder cancer	0.00057	0.0115	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000503	0.0101	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000502	0.0101	CbGpPWpGaD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000473	0.0022	CcSEcCtD
Fluorescein—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.000472	0.00219	CcSEcCtD
Fluorescein—Discomfort—Gemcitabine—urinary bladder cancer	0.000471	0.00219	CcSEcCtD
Fluorescein—Malaise—Cisplatin—urinary bladder cancer	0.000471	0.00219	CcSEcCtD
Fluorescein—CYP1A1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00047	0.00944	CbGpPWpGaD
Fluorescein—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000469	0.00218	CcSEcCtD
Fluorescein—Chest pain—Fluorouracil—urinary bladder cancer	0.000469	0.00218	CcSEcCtD
Fluorescein—Dysgeusia—Etoposide—urinary bladder cancer	0.000468	0.00218	CcSEcCtD
Fluorescein—ABCC1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000467	0.00938	CbGpPWpGaD
Fluorescein—Pain—Thiotepa—urinary bladder cancer	0.000465	0.00216	CcSEcCtD
Fluorescein—Discomfort—Fluorouracil—urinary bladder cancer	0.000463	0.00215	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00046	0.00214	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—urinary bladder cancer	0.000458	0.00213	CcSEcCtD
Fluorescein—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000457	0.00212	CcSEcCtD
Fluorescein—Oedema—Gemcitabine—urinary bladder cancer	0.000457	0.00212	CcSEcCtD
Fluorescein—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000454	0.00211	CcSEcCtD
Fluorescein—Convulsion—Cisplatin—urinary bladder cancer	0.000452	0.0021	CcSEcCtD
Fluorescein—Oedema—Fluorouracil—urinary bladder cancer	0.000449	0.00209	CcSEcCtD
Fluorescein—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000449	0.00209	CcSEcCtD
Fluorescein—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000448	0.00208	CcSEcCtD
Fluorescein—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000448	0.00208	CcSEcCtD
Fluorescein—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000444	0.00206	CcSEcCtD
Fluorescein—Skin disorder—Gemcitabine—urinary bladder cancer	0.000444	0.00206	CcSEcCtD
Fluorescein—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000444	0.00206	CcSEcCtD
Fluorescein—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000442	0.00205	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000441	0.00205	CcSEcCtD
Fluorescein—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000441	0.00205	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—urinary bladder cancer	0.00044	0.00205	CcSEcCtD
Fluorescein—Discomfort—Cisplatin—urinary bladder cancer	0.000439	0.00204	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—SOD2—urinary bladder cancer	0.000439	0.00881	CbGpPWpGaD
Fluorescein—Tachycardia—Fluorouracil—urinary bladder cancer	0.000439	0.00204	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.000436	0.00203	CcSEcCtD
Fluorescein—Urticaria—Thiotepa—urinary bladder cancer	0.000432	0.002	CcSEcCtD
Fluorescein—Malaise—Etoposide—urinary bladder cancer	0.000431	0.002	CcSEcCtD
Fluorescein—Abdominal pain—Thiotepa—urinary bladder cancer	0.000429	0.002	CcSEcCtD
Fluorescein—Hypotension—Gemcitabine—urinary bladder cancer	0.000427	0.00198	CcSEcCtD
Fluorescein—Oedema—Cisplatin—urinary bladder cancer	0.000426	0.00198	CcSEcCtD
Fluorescein—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000426	0.00198	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000425	0.00198	CcSEcCtD
Fluorescein—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000423	0.00197	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000421	0.00846	CbGpPWpGaD
Fluorescein—Loss of consciousness—Etoposide—urinary bladder cancer	0.00042	0.00195	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00042	0.00195	CcSEcCtD
Fluorescein—Hypotension—Fluorouracil—urinary bladder cancer	0.00042	0.00195	CcSEcCtD
Fluorescein—CYP1A1—Oxidative Stress—GPX1—urinary bladder cancer	0.000418	0.0084	CbGpPWpGaD
Fluorescein—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000418	0.00194	CcSEcCtD
Fluorescein—Cough—Etoposide—urinary bladder cancer	0.000417	0.00194	CcSEcCtD
Fluorescein—Tachycardia—Cisplatin—urinary bladder cancer	0.000416	0.00193	CcSEcCtD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000415	0.00835	CbGpPWpGaD
Fluorescein—Convulsion—Etoposide—urinary bladder cancer	0.000414	0.00192	CcSEcCtD
Fluorescein—Skin disorder—Cisplatin—urinary bladder cancer	0.000414	0.00192	CcSEcCtD
Fluorescein—Hypertension—Etoposide—urinary bladder cancer	0.000413	0.00192	CcSEcCtD
Fluorescein—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000412	0.00191	CcSEcCtD
Fluorescein—Asthma—Methotrexate—urinary bladder cancer	0.000411	0.00191	CcSEcCtD
Fluorescein—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00041	0.00191	CcSEcCtD
Fluorescein—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000407	0.00189	CcSEcCtD
Fluorescein—Chest pain—Etoposide—urinary bladder cancer	0.000407	0.00189	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000405	0.00813	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000405	0.00813	CbGpPWpGaD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000404	0.00188	CcSEcCtD
Fluorescein—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000403	0.00187	CcSEcCtD
Fluorescein—Discomfort—Etoposide—urinary bladder cancer	0.000402	0.00187	CcSEcCtD
Fluorescein—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000401	0.00186	CcSEcCtD
Fluorescein—Hypersensitivity—Thiotepa—urinary bladder cancer	0.0004	0.00186	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—GSTO2—urinary bladder cancer	0.000399	0.00802	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—NAT1—urinary bladder cancer	0.000399	0.00802	CbGpPWpGaD
Fluorescein—Hypotension—Cisplatin—urinary bladder cancer	0.000398	0.00185	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000395	0.00183	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000394	0.00183	CcSEcCtD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000394	0.00791	CbGpPWpGaD
Fluorescein—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000392	0.00182	CcSEcCtD
Fluorescein—Pain—Gemcitabine—urinary bladder cancer	0.000391	0.00182	CcSEcCtD
Fluorescein—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00039	0.00181	CcSEcCtD
Fluorescein—Asthenia—Thiotepa—urinary bladder cancer	0.00039	0.00181	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000388	0.0018	CcSEcCtD
Fluorescein—Asthma—Epirubicin—urinary bladder cancer	0.000385	0.00179	CcSEcCtD
Fluorescein—Pruritus—Thiotepa—urinary bladder cancer	0.000384	0.00179	CcSEcCtD
Fluorescein—Pain—Fluorouracil—urinary bladder cancer	0.000384	0.00178	CcSEcCtD
Fluorescein—Paraesthesia—Cisplatin—urinary bladder cancer	0.000382	0.00178	CcSEcCtD
Fluorescein—Tachycardia—Etoposide—urinary bladder cancer	0.000381	0.00177	CcSEcCtD
Fluorescein—Dyspnoea—Cisplatin—urinary bladder cancer	0.00038	0.00176	CcSEcCtD
Fluorescein—Skin disorder—Etoposide—urinary bladder cancer	0.000379	0.00176	CcSEcCtD
Fluorescein—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000377	0.00175	CcSEcCtD
Fluorescein—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000377	0.00175	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—urinary bladder cancer	0.000375	0.00174	CcSEcCtD
Fluorescein—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00037	0.00172	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000368	0.00171	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000365	0.00734	CbGpPWpGaD
Fluorescein—Hypotension—Etoposide—urinary bladder cancer	0.000365	0.00169	CcSEcCtD
Fluorescein—Pain—Cisplatin—urinary bladder cancer	0.000364	0.00169	CcSEcCtD
Fluorescein—CYP1A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00036	0.00724	CbGpPWpGaD
Fluorescein—Dizziness—Thiotepa—urinary bladder cancer	0.000359	0.00167	CcSEcCtD
Fluorescein—Urticaria—Fluorouracil—urinary bladder cancer	0.000357	0.00166	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—urinary bladder cancer	0.000356	0.00165	CcSEcCtD
Fluorescein—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000351	0.00163	CcSEcCtD
Fluorescein—Paraesthesia—Etoposide—urinary bladder cancer	0.00035	0.00163	CcSEcCtD
Fluorescein—Dyspnoea—Etoposide—urinary bladder cancer	0.000348	0.00162	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000347	0.00161	CcSEcCtD
Fluorescein—Vomiting—Thiotepa—urinary bladder cancer	0.000345	0.0016	CcSEcCtD
Fluorescein—Rash—Thiotepa—urinary bladder cancer	0.000343	0.00159	CcSEcCtD
Fluorescein—Dermatitis—Thiotepa—urinary bladder cancer	0.000342	0.00159	CcSEcCtD
Fluorescein—Headache—Thiotepa—urinary bladder cancer	0.00034	0.00158	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000337	0.00157	CcSEcCtD
Fluorescein—Pain—Etoposide—urinary bladder cancer	0.000334	0.00155	CcSEcCtD
Fluorescein—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000331	0.00154	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000329	0.00661	CbGpPWpGaD
Fluorescein—Asthenia—Gemcitabine—urinary bladder cancer	0.000328	0.00152	CcSEcCtD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000324	0.00651	CbGpPWpGaD
Fluorescein—Pruritus—Gemcitabine—urinary bladder cancer	0.000323	0.0015	CcSEcCtD
Fluorescein—Nausea—Thiotepa—urinary bladder cancer	0.000323	0.0015	CcSEcCtD
Fluorescein—Feeling abnormal—Etoposide—urinary bladder cancer	0.000322	0.00149	CcSEcCtD
Fluorescein—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000319	0.00148	CcSEcCtD
Fluorescein—Pruritus—Fluorouracil—urinary bladder cancer	0.000318	0.00148	CcSEcCtD
Fluorescein—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000314	0.00146	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—urinary bladder cancer	0.000313	0.00146	CcSEcCtD
Fluorescein—Urticaria—Etoposide—urinary bladder cancer	0.00031	0.00144	CcSEcCtD
Fluorescein—Abdominal pain—Etoposide—urinary bladder cancer	0.000308	0.00143	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000306	0.00142	CcSEcCtD
Fluorescein—Asthenia—Cisplatin—urinary bladder cancer	0.000306	0.00142	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000305	0.00142	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—urinary bladder cancer	0.000298	0.00139	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—urinary bladder cancer	0.000297	0.00138	CcSEcCtD
Fluorescein—Dizziness—Fluorouracil—urinary bladder cancer	0.000297	0.00138	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000297	0.00138	CcSEcCtD
Fluorescein—Chills—Methotrexate—urinary bladder cancer	0.000295	0.00137	CcSEcCtD
Fluorescein—Vomiting—Gemcitabine—urinary bladder cancer	0.000291	0.00135	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—urinary bladder cancer	0.00029	0.00135	CcSEcCtD
Fluorescein—Rash—Gemcitabine—urinary bladder cancer	0.000288	0.00134	CcSEcCtD
Fluorescein—Dermatitis—Gemcitabine—urinary bladder cancer	0.000288	0.00134	CcSEcCtD
Fluorescein—Hypersensitivity—Etoposide—urinary bladder cancer	0.000287	0.00134	CcSEcCtD
Fluorescein—Erythema—Methotrexate—urinary bladder cancer	0.000286	0.00133	CcSEcCtD
Fluorescein—Headache—Gemcitabine—urinary bladder cancer	0.000286	0.00133	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000286	0.00133	CcSEcCtD
Fluorescein—Vomiting—Fluorouracil—urinary bladder cancer	0.000286	0.00133	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000283	0.00132	CcSEcCtD
Fluorescein—Rash—Fluorouracil—urinary bladder cancer	0.000283	0.00132	CcSEcCtD
Fluorescein—Dermatitis—Fluorouracil—urinary bladder cancer	0.000283	0.00131	CcSEcCtD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000282	0.00567	CbGpPWpGaD
Fluorescein—Headache—Fluorouracil—urinary bladder cancer	0.000281	0.00131	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—urinary bladder cancer	0.00028	0.0013	CcSEcCtD
Fluorescein—Asthenia—Etoposide—urinary bladder cancer	0.00028	0.0013	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—urinary bladder cancer	0.000279	0.0013	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—urinary bladder cancer	0.000278	0.00129	CcSEcCtD
Fluorescein—CYP1A1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000278	0.00559	CbGpPWpGaD
Fluorescein—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000277	0.00129	CcSEcCtD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000277	0.00556	CbGpPWpGaD
Fluorescein—Chills—Epirubicin—urinary bladder cancer	0.000276	0.00128	CcSEcCtD
Fluorescein—Pruritus—Etoposide—urinary bladder cancer	0.000276	0.00128	CcSEcCtD
Fluorescein—ABCC1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000275	0.00552	CbGpPWpGaD
Fluorescein—Nausea—Gemcitabine—urinary bladder cancer	0.000271	0.00126	CcSEcCtD
Fluorescein—Vomiting—Cisplatin—urinary bladder cancer	0.000271	0.00126	CcSEcCtD
Fluorescein—Rash—Cisplatin—urinary bladder cancer	0.000269	0.00125	CcSEcCtD
Fluorescein—Dermatitis—Cisplatin—urinary bladder cancer	0.000268	0.00125	CcSEcCtD
Fluorescein—Erythema—Epirubicin—urinary bladder cancer	0.000268	0.00125	CcSEcCtD
Fluorescein—Nausea—Fluorouracil—urinary bladder cancer	0.000267	0.00124	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000266	0.00123	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000264	0.00123	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—urinary bladder cancer	0.000262	0.00122	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—urinary bladder cancer	0.000258	0.0012	CcSEcCtD
Fluorescein—Malaise—Methotrexate—urinary bladder cancer	0.000258	0.0012	CcSEcCtD
Fluorescein—Dizziness—Etoposide—urinary bladder cancer	0.000258	0.0012	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000257	0.0012	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000257	0.00119	CcSEcCtD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000256	0.00514	CbGpPWpGaD
Fluorescein—Chills—Doxorubicin—urinary bladder cancer	0.000256	0.00119	CcSEcCtD
Fluorescein—Nausea—Cisplatin—urinary bladder cancer	0.000253	0.00118	CcSEcCtD
Fluorescein—Cough—Methotrexate—urinary bladder cancer	0.00025	0.00116	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000249	0.00116	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—urinary bladder cancer	0.000248	0.00115	CcSEcCtD
Fluorescein—Vomiting—Etoposide—urinary bladder cancer	0.000248	0.00115	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—urinary bladder cancer	0.000248	0.00115	CcSEcCtD
Fluorescein—Rash—Etoposide—urinary bladder cancer	0.000246	0.00114	CcSEcCtD
Fluorescein—Dermatitis—Etoposide—urinary bladder cancer	0.000246	0.00114	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000245	0.00492	CbGpPWpGaD
Fluorescein—Headache—Etoposide—urinary bladder cancer	0.000244	0.00114	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—urinary bladder cancer	0.000244	0.00113	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000244	0.0049	CbGpPWpGaD
Fluorescein—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000243	0.00113	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000242	0.00112	CcSEcCtD
Fluorescein—Malaise—Epirubicin—urinary bladder cancer	0.000242	0.00112	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—urinary bladder cancer	0.000241	0.00112	CcSEcCtD
Fluorescein—Syncope—Epirubicin—urinary bladder cancer	0.00024	0.00112	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000236	0.00109	CcSEcCtD
Fluorescein—Cough—Epirubicin—urinary bladder cancer	0.000234	0.00109	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000234	0.00109	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—urinary bladder cancer	0.000232	0.00108	CcSEcCtD
Fluorescein—Nausea—Etoposide—urinary bladder cancer	0.000232	0.00108	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—urinary bladder cancer	0.000231	0.00107	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00023	0.00107	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000229	0.00106	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—urinary bladder cancer	0.000228	0.00106	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—urinary bladder cancer	0.000227	0.00105	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000227	0.00105	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000226	0.00105	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—urinary bladder cancer	0.000225	0.00105	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—urinary bladder cancer	0.000224	0.00104	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—urinary bladder cancer	0.000222	0.00103	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—NAT2—urinary bladder cancer	0.000219	0.0044	CbGpPWpGaD
Fluorescein—Oedema—Epirubicin—urinary bladder cancer	0.000219	0.00102	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000219	0.00102	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—urinary bladder cancer	0.000218	0.00101	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000218	0.00101	CcSEcCtD
Fluorescein—Cough—Doxorubicin—urinary bladder cancer	0.000216	0.00101	CcSEcCtD
Fluorescein—CYP1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000216	0.00433	CbGpPWpGaD
Fluorescein—Shock—Epirubicin—urinary bladder cancer	0.000215	0.001	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—urinary bladder cancer	0.000215	0.000998	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000215	0.000997	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—urinary bladder cancer	0.000214	0.000995	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—urinary bladder cancer	0.000213	0.000992	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000213	0.00428	CbGpPWpGaD
Fluorescein—Skin disorder—Epirubicin—urinary bladder cancer	0.000212	0.000987	CcSEcCtD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000212	0.00426	CbGpPWpGaD
Fluorescein—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000211	0.000982	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—urinary bladder cancer	0.000211	0.000981	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—urinary bladder cancer	0.00021	0.000975	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00021	0.000974	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—urinary bladder cancer	0.000209	0.000969	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—urinary bladder cancer	0.000208	0.000968	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—urinary bladder cancer	0.000204	0.00095	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000202	0.00094	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—urinary bladder cancer	0.000202	0.00094	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000202	0.000937	CcSEcCtD
Fluorescein—Pain—Methotrexate—urinary bladder cancer	0.0002	0.000929	CcSEcCtD
Fluorescein—Shock—Doxorubicin—urinary bladder cancer	0.000199	0.000925	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000198	0.000922	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—urinary bladder cancer	0.000198	0.000918	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—urinary bladder cancer	0.000197	0.000913	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—urinary bladder cancer	0.000196	0.000912	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000196	0.000909	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—urinary bladder cancer	0.000195	0.000906	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000193	0.000895	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000191	0.000888	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—urinary bladder cancer	0.000189	0.000879	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000189	0.000877	CcSEcCtD
Fluorescein—Pain—Epirubicin—urinary bladder cancer	0.000187	0.000869	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—urinary bladder cancer	0.000186	0.000863	CcSEcCtD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000185	0.00371	CbGpPWpGaD
Fluorescein—Abdominal pain—Methotrexate—urinary bladder cancer	0.000185	0.000858	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000182	0.000844	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00018	0.000838	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00018	0.000837	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000179	0.000831	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000177	0.00356	CbGpPWpGaD
Fluorescein—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000176	0.00354	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000175	0.00351	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.000175	0.00351	CbGpPWpGaD
Fluorescein—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000175	0.000812	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—urinary bladder cancer	0.000174	0.000807	CcSEcCtD
Fluorescein—Pain—Doxorubicin—urinary bladder cancer	0.000173	0.000804	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—urinary bladder cancer	0.000173	0.000803	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000172	0.0008	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00017	0.00341	CbGpPWpGaD
Fluorescein—Asthenia—Methotrexate—urinary bladder cancer	0.000168	0.000779	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000167	0.000775	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000166	0.000769	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—urinary bladder cancer	0.000165	0.000768	CcSEcCtD
Fluorescein—CYP1A1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000164	0.00329	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000162	0.00326	CbGpPWpGaD
Fluorescein—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000161	0.000749	CcSEcCtD
Fluorescein—ABCB11—Metabolism—GSTZ1—urinary bladder cancer	0.000161	0.00323	CbGpPWpGaD
Fluorescein—Urticaria—Doxorubicin—urinary bladder cancer	0.000161	0.000747	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00016	0.000743	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—urinary bladder cancer	0.000157	0.000729	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—urinary bladder cancer	0.000155	0.000719	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—urinary bladder cancer	0.000155	0.000718	CcSEcCtD
Fluorescein—CYP1A1—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000155	0.0031	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000153	0.00307	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTO2—urinary bladder cancer	0.000153	0.00307	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NAT1—urinary bladder cancer	0.000153	0.00307	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000151	0.00304	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000151	0.00303	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00015	0.00302	CbGpPWpGaD
Fluorescein—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000149	0.000693	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—urinary bladder cancer	0.000149	0.00069	CcSEcCtD
Fluorescein—Rash—Methotrexate—urinary bladder cancer	0.000147	0.000685	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—urinary bladder cancer	0.000147	0.000684	CcSEcCtD
Fluorescein—Headache—Methotrexate—urinary bladder cancer	0.000146	0.00068	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000146	0.00292	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000146	0.00292	CbGpPWpGaD
Fluorescein—Asthenia—Doxorubicin—urinary bladder cancer	0.000145	0.000675	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—urinary bladder cancer	0.000145	0.000672	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000144	0.0029	CbGpPWpGaD
Fluorescein—Pruritus—Doxorubicin—urinary bladder cancer	0.000143	0.000665	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000142	0.00284	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000142	0.00284	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—UGT2B7—urinary bladder cancer	0.00014	0.0028	CbGpPWpGaD
Fluorescein—Vomiting—Epirubicin—urinary bladder cancer	0.000139	0.000646	CcSEcCtD
Fluorescein—Nausea—Methotrexate—urinary bladder cancer	0.000139	0.000645	CcSEcCtD
Fluorescein—Rash—Epirubicin—urinary bladder cancer	0.000138	0.000641	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—urinary bladder cancer	0.000138	0.00064	CcSEcCtD
Fluorescein—Headache—Epirubicin—urinary bladder cancer	0.000137	0.000637	CcSEcCtD
Fluorescein—ABCC1—Disease—GSTO2—urinary bladder cancer	0.000137	0.00275	CbGpPWpGaD
Fluorescein—Dizziness—Doxorubicin—urinary bladder cancer	0.000134	0.000622	CcSEcCtD
Fluorescein—Nausea—Epirubicin—urinary bladder cancer	0.00013	0.000604	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—urinary bladder cancer	0.000129	0.000598	CcSEcCtD
Fluorescein—Rash—Doxorubicin—urinary bladder cancer	0.000128	0.000593	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—urinary bladder cancer	0.000127	0.000592	CcSEcCtD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000127	0.00255	CbGpPWpGaD
Fluorescein—Headache—Doxorubicin—urinary bladder cancer	0.000127	0.000589	CcSEcCtD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000126	0.00254	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP4B1—urinary bladder cancer	0.000126	0.00252	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000124	0.00249	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000124	0.00249	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTZ1—urinary bladder cancer	0.000121	0.00243	CbGpPWpGaD
Fluorescein—Nausea—Doxorubicin—urinary bladder cancer	0.00012	0.000558	CcSEcCtD
Fluorescein—ABCB11—Metabolism—SLC19A1—urinary bladder cancer	0.000119	0.00238	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000118	0.00237	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000118	0.00237	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000118	0.00236	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000117	0.00235	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000116	0.00233	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PRSS3—urinary bladder cancer	0.000116	0.00232	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTO2—urinary bladder cancer	0.000115	0.0023	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NAT1—urinary bladder cancer	0.000115	0.0023	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000113	0.00227	CbGpPWpGaD
Fluorescein—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000111	0.00222	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000108	0.00218	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000108	0.00217	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000107	0.00214	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SLC19A1—urinary bladder cancer	0.000106	0.00214	CbGpPWpGaD
Fluorescein—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000106	0.00214	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—UGT2B7—urinary bladder cancer	0.000105	0.00211	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000104	0.00209	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000104	0.00209	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PRSS3—urinary bladder cancer	0.000104	0.00208	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000102	0.00204	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.96e-05	0.002	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HDAC4—urinary bladder cancer	9.9e-05	0.00199	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.75e-05	0.00196	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP4B1—urinary bladder cancer	9.44e-05	0.0019	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.27e-05	0.00186	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—TYMP—urinary bladder cancer	9.25e-05	0.00186	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SLC19A1—urinary bladder cancer	8.92e-05	0.00179	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.88e-05	0.00178	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PRSS3—urinary bladder cancer	8.69e-05	0.00175	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NAT2—urinary bladder cancer	8.36e-05	0.00168	CbGpPWpGaD
Fluorescein—ABCC1—Disease—LIG1—urinary bladder cancer	7.86e-05	0.00158	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	7.47e-05	0.0015	CbGpPWpGaD
Fluorescein—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	7.25e-05	0.00146	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—RRM2—urinary bladder cancer	7.22e-05	0.00145	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	7.2e-05	0.00145	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	7.17e-05	0.00144	CbGpPWpGaD
Fluorescein—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	7.09e-05	0.00142	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.97e-05	0.0014	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TYMP—urinary bladder cancer	6.95e-05	0.0014	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	6.83e-05	0.00137	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NAT1—urinary bladder cancer	6.83e-05	0.00137	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.72e-05	0.00135	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ENO2—urinary bladder cancer	6.69e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—HPGDS—urinary bladder cancer	6.69e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.67e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.65e-05	0.00134	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTT1—urinary bladder cancer	6.48e-05	0.0013	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.38e-05	0.00128	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NAT2—urinary bladder cancer	6.28e-05	0.00126	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	6.25e-05	0.00125	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ENO2—urinary bladder cancer	6e-05	0.0012	CbGpPWpGaD
Fluorescein—ABCC1—Disease—RBX1—urinary bladder cancer	5.69e-05	0.00114	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	5.62e-05	0.00113	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—RRM2—urinary bladder cancer	5.42e-05	0.00109	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NQO1—urinary bladder cancer	5.39e-05	0.00108	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	5.31e-05	0.00107	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.23e-05	0.00105	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	5.18e-05	0.00104	CbGpPWpGaD
Fluorescein—ABCC1—Disease—JAG1—urinary bladder cancer	5.09e-05	0.00102	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—HPGDS—urinary bladder cancer	5.02e-05	0.00101	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ENO2—urinary bladder cancer	5.02e-05	0.00101	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.99e-05	0.001	CbGpPWpGaD
Fluorescein—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	4.89e-05	0.000981	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTT1—urinary bladder cancer	4.87e-05	0.000978	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.8e-05	0.000963	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.76e-05	0.000957	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.56e-05	0.000916	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.56e-05	0.000916	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTP1—urinary bladder cancer	4.49e-05	0.000903	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.35e-05	0.000873	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—TYMS—urinary bladder cancer	4.18e-05	0.000839	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.15e-05	0.000834	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TYMP—urinary bladder cancer	4.14e-05	0.000831	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GSTM1—urinary bladder cancer	4.13e-05	0.00083	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—NCOR1—urinary bladder cancer	4.13e-05	0.00083	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NQO1—urinary bladder cancer	4.05e-05	0.000813	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.97e-05	0.000798	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GPX1—urinary bladder cancer	3.96e-05	0.000794	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.93e-05	0.000789	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ERCC2—urinary bladder cancer	3.88e-05	0.00078	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NAT2—urinary bladder cancer	3.74e-05	0.000752	CbGpPWpGaD
Fluorescein—ABCC1—Disease—NCOR1—urinary bladder cancer	3.7e-05	0.000744	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—MTHFR—urinary bladder cancer	3.65e-05	0.000733	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERCC2—urinary bladder cancer	3.48e-05	0.0007	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.43e-05	0.000688	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTP1—urinary bladder cancer	3.38e-05	0.000678	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MTHFR—urinary bladder cancer	3.27e-05	0.000658	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.27e-05	0.000656	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TERT—urinary bladder cancer	3.27e-05	0.000656	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—RRM2—urinary bladder cancer	3.23e-05	0.000649	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—TYMS—urinary bladder cancer	3.14e-05	0.000631	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—NCOR1—urinary bladder cancer	3.1e-05	0.000623	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GSTM1—urinary bladder cancer	3.1e-05	0.000623	CbGpPWpGaD
Fluorescein—ABCC1—Disease—FGFR3—urinary bladder cancer	3e-05	0.000602	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ENO2—urinary bladder cancer	2.99e-05	0.000601	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	2.99e-05	0.000601	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.97e-05	0.000597	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GPX1—urinary bladder cancer	2.97e-05	0.000597	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PPARG—urinary bladder cancer	2.96e-05	0.000595	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ERCC2—urinary bladder cancer	2.92e-05	0.000586	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	2.9e-05	0.000583	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.86e-05	0.000574	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CREBBP—urinary bladder cancer	2.84e-05	0.000571	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—MTHFR—urinary bladder cancer	2.74e-05	0.000551	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CREBBP—urinary bladder cancer	2.55e-05	0.000512	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NQO1—urinary bladder cancer	2.41e-05	0.000484	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.34e-05	0.00047	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PTGS2—urinary bladder cancer	2.33e-05	0.000468	CbGpPWpGaD
Fluorescein—ABCC1—Disease—RHOA—urinary bladder cancer	2.31e-05	0.000463	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PPARG—urinary bladder cancer	2.22e-05	0.000447	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CREBBP—urinary bladder cancer	2.14e-05	0.000429	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ERBB2—urinary bladder cancer	2.14e-05	0.000429	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTGS2—urinary bladder cancer	2.09e-05	0.00042	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.04e-05	0.00041	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—PTEN—urinary bladder cancer	2.03e-05	0.000408	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	2.01e-05	0.000404	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.95e-05	0.000391	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—EP300—urinary bladder cancer	1.94e-05	0.000389	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.87e-05	0.000376	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.85e-05	0.000371	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.85e-05	0.000371	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.83e-05	0.000367	CbGpPWpGaD
Fluorescein—ABCC1—Disease—PTEN—urinary bladder cancer	1.82e-05	0.000366	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.77e-05	0.000355	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.75e-05	0.000351	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.74e-05	0.000349	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EP300—urinary bladder cancer	1.74e-05	0.000349	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SRC—urinary bladder cancer	1.69e-05	0.000339	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.63e-05	0.000328	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.53e-05	0.000306	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MYC—urinary bladder cancer	1.51e-05	0.000304	CbGpPWpGaD
Fluorescein—ABCC1—Disease—EGFR—urinary bladder cancer	1.48e-05	0.000297	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—EP300—urinary bladder cancer	1.45e-05	0.000292	CbGpPWpGaD
Fluorescein—ABCC1—Disease—KRAS—urinary bladder cancer	1.4e-05	0.000281	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PPARG—urinary bladder cancer	1.32e-05	0.000266	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	0.000256	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HRAS—urinary bladder cancer	1.19e-05	0.000239	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	0.000209	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—PTEN—urinary bladder cancer	9.09e-06	0.000183	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—EP300—urinary bladder cancer	8.67e-06	0.000174	CbGpPWpGaD
